During the past decade, Pulmonary Disease Specialists, PA d/b/a PDS Research conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 5 clinical trials were completed, i.e. on average, 41.7% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 3 clinical trials were completed. i.e. 37.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Pulmonary Disease Specialists, PA d/b/a PDS Research" #1 sponsor was "International Biophysics Corporation" with 2 trials, followed by "Millennium Pharmaceuticals, Inc." with 2 trials sponsored, "United Therapeutics" with 2 trials sponsored, "Jazz Pharmaceuticals" with 1 trials sponsored and "Kadmon Corporation, LLC" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Pulmonary Disease Specialists, PA d/b/a PDS Research" #1 collaborator was "Iqvia Pty Ltd" with 1 trials as a collaborator and "LGC Limited" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Pulmonary Disease Specialists, PA d/b/a PDS Research" are "Idiopathic Pulmonary Fibrosis" (3 trials), "Bronchiectasis" (2 trials), "COPD" (2 trials), "Cystic Fibrosis" (2 trials) and "Interstitial Lung Disease" (2 trials). Many other conditions were trialed in "Pulmonary Disease Specialists, PA d/b/a PDS Research" in a lesser frequency.

Most popular intervention types in "Pulmonary Disease Specialists, PA d/b/a PDS Research" are "Drug" (9 trials), "Device" (4 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Inhaled Treprostinil" (2 trials), "International Biophysics AffloVest" (2 trials), "TAK-925" (2 trials) and "Treprostinil Ultrasonic Nebulizer" (2 trials). Other intervention names were less common.

The vast majority of trials in "Pulmonary Disease Specialists, PA d/b/a PDS Research" are 12 trials for "All" genders.

Currently, there are NaN active trials in "Pulmonary Disease Specialists, PA d/b/a PDS Research". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 9 completed trials in Pulmonary Disease Specialists, PA d/b/a PDS Research, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Pulmonary Disease Specialists, PA d/b/a PDS Research, 2 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".